These findings reveal AKR1B10 as a critical regulator of PP2A enzymatic activity and underscore the therapeutic potential of restoring PP2A activity to counteract AKR1B10 loss–driven CRC metastasis. Here, AKR1B10 is linked to colorectal carcinoma.